Navigation Links
Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation

New York, New York (PRWEB) May 19, 2013

The Pradaxa lawyers at Bernstein Liebhard LLP note that a Case Management Conference was recently convened for hundreds of Pradaxa bleeding lawsuits pending in a federal multidistrict litigation now underway in U.S. District Court, Southern District of Illinois. According to Minutes posted on the Court’s website on May 14th, the Conference addressed the status of depositions and pending motions. It was also reported during the Conference that Defendants submitted a list of early trial eligible cases to the Court and Plaintiffs’ co-lead counsel last month, and that the parties have revised and finalized the list. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are pleased to see the federal Pradaxa litigation moving forward. We continue to receive inquiries from Pradaxa users who have allegedly suffered frightening episodes of internal bleeding while being treated with this blood thinner,” said Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm’s Pradaxa lawyers are currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Side Effect Lawsuits
Court records indicate that 711 Pradaxa lawsuits are currently pending in the Southern District of Illinois. All of the lawsuits allege Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for Pradaxa bleeding. The first trial in the litigation is scheduled to start in September 2014.

Pradaxa was approved for sale by the U.S. Food & Drug Administration (FDA) in October 2010 to prevent strokes in people with atrial fibrillation, and was supposed to provide an improved alternative to warfarin. But according to a report published by in December, regulators in several countries have issued Pradaxa bleeding alerts since the drug’s launch. One real danger is the fact that there exists no readily-available antidote for internal bleeding, a potentially life-threatening Pradaxa side effect. *

On May 1st, the Journal of Neurosurgery published a study that showed head trauma victims were more likely to die from brain bleeding if they had been using Pradaxa compared to those taking warfarin. The authors of the research said that the absence of an effective reversal agent could account for the higher death rate among Pradaxa patients.** In January, an analysis of FDA hemorrhage cases published in the Institute for Safe Medication Practice’s QuarterWatch report revealed Pradaxa bleeding was 5 times more likely to have a fatal outcome compared to warfarin bleeding.***

Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. Additional information regarding Pradaxa lawsuits is available at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation with a Pradaxa lawyer, please call 800-511-5092.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuit Update: Bernstein Liebhard LLP Notes Filings in Federal Pradaxa Litigation Surpass 700
2. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
3. Rottenstein Law Group LLP Responds to Study Linking Pradaxa Side Effects with Potential Mortality Risks
4. Update on Pradaxa Internal Bleeding Problem Allegations Lawsuits; Resource4thePeople Reports Bellwether Trial Dates Scheduled
5. Pradaxa Lawyers at Bernstein Liebhard LLP Comment on New Study Highlighting the Risk of Pradaxa Brain Bleeding
6. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
7. Pradaxa Lawsuits Move Forward, With Scheduling of Next Status Conference in Federal Pradaxa Litigation, Bernstein Liebhard LLP Reports
8. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
9. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
10. DrugRisk Adds Study Showing Pradaxa May Increase Viral Infection Risk
11. 2013 Cases Involving Pradaxa Internal Bleeding Problem Allegations Now Being Investigated by Resource4thePeople Lawyers
Post Your Comments:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: